相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Xiaopin Duan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Pursuing Specific Chemotherapy of Orthotopic Breast Cancer with Lung Metastasis from Docking Nanoparticles Driven by Bioinspired Exosomes
Fei Xiong et al.
NANO LETTERS (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Xiaopin Duan et al.
NATURE COMMUNICATIONS (2019)
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Mengying Hu et al.
NATURE COMMUNICATIONS (2019)
Advancing Cancer Immunotherapies with Nanotechnology
Jenny Lou et al.
ADVANCED THERAPEUTICS (2019)
Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
Xudong Zhang et al.
ADVANCED MATERIALS (2018)
Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance
Xiang Ling et al.
NANO LETTERS (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Biomimetic Shells Endow Sub-50 nm Nanoparticles with Ultrahigh Paclitaxel Payloads for Specific and Robust Chemotherapy
Xing Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan et al.
CHEMICAL REVIEWS (2017)
Cellular uptake of nanoparticles: journey inside the cell
Shahed Behzadi et al.
CHEMICAL SOCIETY REVIEWS (2017)
Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy
Xiaoding Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Jonathan M. Pitt et al.
IMMUNITY (2016)
Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer
Chunbai He et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant Ovarian Cancer
Christopher Poon et al.
MOLECULAR PHARMACEUTICS (2016)
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
Danny N. Khalil et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Reporter nanoparticle that monitors its anticancer efficacy in real time
Ashish Kulkarni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Arsenic trioxide inhibits lung metastasis of mouse colon cancer via reducing the infiltration of regulatory T cells
Lei Wang et al.
TUMOR BIOLOGY (2016)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumor-targeting delivery of hyaluronic acid-platinum(IV) nanoconjugate to reduce toxicity and improve survival
Xiang Ling et al.
POLYMER CHEMISTRY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Calcium phosphate nanoparticles primarily induce cell necrosis through lysosomal rupture: the origination of material cytotoxicity
Zhaoming Liu et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
Michael H. Kershaw et al.
ONCOIMMUNOLOGY (2013)
Cardiac Glycosides Exert Anticancer Effects by Inducing Immunogenic Cell Death
Laurie Menger et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Differentially Charged Hollow Core/Shell Lipid-Polymer-Lipid Hybrid Nanoparticles for Small Interfering RNA Delivery
Jinjun Shi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28
Jacalyn Rosenblatt et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Direct cellular responses to platinum-induced DNA damage
Yongwon Jung et al.
CHEMICAL REVIEWS (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Toxic proteins released from mitochondria in cell death
X Saelens et al.
ONCOGENE (2004)
Time response of carboplatin-induced nephrotoxicity in rats
K Husain et al.
PHARMACOLOGICAL RESEARCH (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations
RB Sekar et al.
JOURNAL OF CELL BIOLOGY (2003)